Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[BCG potentiates the immunodepression induced by cyclophosphamide]

G Mathé, O Halle-Pannenko, C Bourut

Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles

|April 14, 1975

Summary

Bacillus Calmette-Guerin (BCG) and cyclophosphamide (CPM) combination therapy significantly improves allogeneic skin graft survival. This suggests BCG may enhance lymphocyte sensitivity to CPM, a cell cycle-dependent agent.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13.

Nature genetics·2001

Same author

Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy.

Diabetes·2000

Same author

A new missense mutation in the calcium-sensing receptor in familial benign hypercalcaemia associated with partial lipoatrophy and insulin resistant diabetes.

Clinical endocrinology·2000

Same author

Human hormone-sensitive lipase: genetic mapping, identification of a new dinucleotide repeat, and association with obesity and NIDDM.

Diabetes·1998

Same author

Genetic exclusion of 14 candidate genes in lipoatropic diabetes using linkage analysis in 10 consanguineous families.

The Journal of clinical endocrinology and metabolism·1997

Same author

In vivo eradication of Friend virus as an experimental HIV-model, by combination of zidovudine, acriflavine and an ellipticine analogue. Possible application to the treatment of human pre-AIDS?

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·1994

Area of Science:

Immunology
Transplantation Biology
Pharmacology

Background:

Allogeneic skin graft rejection remains a significant challenge in transplantation.
Cyclophosphamide (CPM) is an immunosuppressive agent with known effects on lymphocyte populations.
Bacillus Calmette-Guerin (BCG) is an immunotherapy agent with complex immunomodulatory properties.

Purpose of the Study:

To investigate the combined effect of BCG and CPM on allogeneic skin graft survival.
To explore the potential mechanisms underlying enhanced graft survival.

Main Methods:

Allogeneic C3H skin grafts were transplanted onto F1 hybrid recipients (DBA/2 X C57Bl/6).
Recipients received BCG (1 mg/mouse) 14 days prior to grafting.
Recipients received CPM (80 or 134 mg/kg) one day post-grafting.

Related Experiment Videos

Graft survival was monitored and compared to control groups.

Main Results:

Combined BCG and CPM treatment significantly enhanced allogeneic skin graft survival compared to CPM alone.
The enhancement was observed with both tested doses of CPM.
No other mechanisms were entirely excluded, but a primary hypothesis was formed.

Conclusions:

The combination of BCG and CPM offers a promising strategy for improving allogeneic skin graft survival.
BCG may potentiate CPM's efficacy by stimulating lymphocytes to enter a cell cycle phase sensitive to CPM.
Further research is warranted to elucidate the precise immunomodulatory mechanisms involved.